🔆 Exciting News for Investors in Biotech Innovation! 🔆 We are thrilled to share a major milestone for FUTR BIO, where innovation meets impact in biotech. Our recent proof-of-concept preclinical data demonstrates compelling results: our mRNA vaccine platform delivers robust protection at low doses, promising long-term safety and efficacy. This breakthrough underscores our commitment to revolutionizing healthcare through synthetic biology. Learn more about our groundbreaking approach: https://futr.bio/ Why Invest in FUTR BIO? ✨Advanced Technology: Harnessing synthetic biology to pioneer next-gen therapies. ✨Market Potential: Addressing critical medical needs with scalable solutions. ✨Proven Results: Exciting preclinical data supports vaccine effectiveness and safety. ✨ Experienced Team: Led by a passionate team of industry experts and visionaries. We invite visionary investors to join us in shaping the future of biotechnology. Let’s collaborate to bring these transformative solutions to the global stage. Curious to learn more about our journey? Let's connect and explore how you can contribute to the FUTR BIO vision! #BiotechInnovation #HealthcareRevolution #InvestInFutrBio #SyntheticBiology #StartupInvestment #HealthTech
FUTR BIO
Pesquisa biotecnológica
Florianópolis, Santa Catarina 362 seguidores
We develop next generation mRNA vaccines to prevent and cure diseases such as infections and cancer.
Sobre nós
FUTR BIO is a biotechnology company focused on developing next generation mRNA vaccines. FUTR BIO proprietary mRNA vaccine technology incorporates natural UTRs and molecular boosters to provide superior immune responses against infectious diseases and cancer.
- Site
-
https://futr.bio/
Link externo para FUTR BIO
- Setor
- Pesquisa biotecnológica
- Tamanho da empresa
- 2-10 funcionários
- Sede
- Florianópolis, Santa Catarina
- Tipo
- Sociedade
- Fundada em
- 2022
Localidades
-
Principal
Como chegar
Rod. José Carlos Daux, 6997 - Santo Antonio de Lisboa
Florianópolis, Santa Catarina 88050-000, BR